Annual Shareholders Equity
-$482.00 K
+$24.00 K+4.74%
31 December 2022
Summary:
Nymox Pharmaceutical annual stockholders equity is currently -$482.00 thousand, with the most recent change of +$24.00 thousand (+4.74%) on 31 December 2022. During the last 3 years, it has fallen by -$2.63 million (-122.47%).NYMX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$1.80 M
-$1.32 M-273.24%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly stockholders equity is currently -$1.80 million, with the most recent change of -$1.32 million (-273.24%) on 31 March 2023.NYMX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -122.5% | -213.6% |
| 5 y5 years | -106.9% | -131.8% |
NYMX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -106.9% | -117.8% |
Nymox Pharmaceutical Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$1.80 M(+273.2%) |
| Dec 2022 | -$482.00 K(-4.7%) | -$482.00 K(-162.4%) |
| Sept 2022 | - | $773.00 K(-65.4%) |
| June 2022 | - | $2.23 M(-260.6%) |
| Mar 2022 | - | -$1.39 M(+174.7%) |
| Dec 2021 | -$506.00 K(-123.6%) | -$506.00 K(-132.0%) |
| Sept 2021 | - | $1.58 M(-66.4%) |
| June 2021 | - | $4.71 M(<-9900.0%) |
| Mar 2021 | - | -$12.00 K(-100.6%) |
| Dec 2020 | $2.15 M(-37.8%) | $2.15 M(-44.2%) |
| Sept 2020 | - | $3.84 M(-461.3%) |
| June 2020 | - | -$1.06 M(-173.8%) |
| Mar 2020 | - | $1.44 M(-58.2%) |
| Dec 2019 | $3.45 M(-50.8%) | $3.45 M(-39.0%) |
| Sept 2019 | - | $5.65 M(-25.3%) |
| June 2019 | - | $7.57 M(-25.0%) |
| Mar 2019 | - | $10.09 M(+44.1%) |
| Dec 2018 | $7.00 M(-659.7%) | $7.00 M(+78.2%) |
| Sept 2018 | - | $3.93 M(+10.7%) |
| June 2018 | - | $3.55 M(-440.1%) |
| Mar 2018 | - | -$1.04 M(-16.5%) |
| Dec 2017 | -$1.25 M(+416.9%) | -$1.25 M(<-9900.0%) |
| Sept 2017 | - | $8900.00(-101.2%) |
| June 2017 | - | -$718.60 K(-38.5%) |
| Mar 2017 | - | -$1.17 M(+383.2%) |
| Dec 2016 | -$242.00 K(-89.7%) | -$242.00 K(-86.7%) |
| Sept 2016 | - | -$1.82 M(-30.1%) |
| June 2016 | - | -$2.60 M(+36.8%) |
| Mar 2016 | - | -$1.90 M(-19.3%) |
| Dec 2015 | -$2.35 M(-48.6%) | -$2.35 M(-33.1%) |
| Sept 2015 | - | -$3.51 M(+51.3%) |
| June 2015 | - | -$2.32 M(-16.7%) |
| Mar 2015 | - | -$2.79 M(-39.1%) |
| Dec 2014 | -$4.58 M(-29.1%) | -$4.58 M(-8.1%) |
| Sept 2014 | - | -$4.99 M(-19.1%) |
| June 2014 | - | -$6.16 M(-7.3%) |
| Mar 2014 | - | -$6.65 M(+3.0%) |
| Dec 2013 | -$6.46 M(-17.7%) | -$6.46 M(+2.6%) |
| Sept 2013 | - | -$6.30 M(-13.3%) |
| June 2013 | - | -$7.26 M(+4.9%) |
| Mar 2013 | - | -$6.92 M(-11.8%) |
| Dec 2012 | -$7.84 M(+40.1%) | -$7.84 M(-3.6%) |
| Sept 2012 | - | -$8.14 M(+0.7%) |
| June 2012 | - | -$8.08 M(+9.4%) |
| Mar 2012 | - | -$7.38 M(+31.9%) |
| Dec 2011 | -$5.60 M(+96.1%) | -$5.60 M(-5.1%) |
| Sept 2011 | - | -$5.90 M(+7.0%) |
| June 2011 | - | -$5.51 M(+48.9%) |
| Mar 2011 | - | -$3.70 M(+29.7%) |
| Dec 2010 | -$2.85 M | -$2.85 M(+56.9%) |
| Sept 2010 | - | -$1.82 M(+10.1%) |
| June 2010 | - | -$1.65 M(+64.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | -$1.01 M(-30.7%) |
| Dec 2009 | -$1.45 M(+11.1%) | -$1.45 M(+98.7%) |
| Sept 2009 | - | -$730.70 K(-33.4%) |
| June 2009 | - | -$1.10 M(-11.7%) |
| Mar 2009 | - | -$1.24 M(-5.0%) |
| Dec 2008 | -$1.31 M(-160.4%) | -$1.31 M(-167.7%) |
| Sept 2008 | - | $1.93 M(+1.9%) |
| June 2008 | - | $1.90 M(-19.9%) |
| Mar 2008 | - | $2.37 M(+9.3%) |
| Dec 2007 | $2.17 M(+111.0%) | $2.17 M(-10.2%) |
| Sept 2007 | - | $2.41 M(-23.4%) |
| June 2007 | - | $3.15 M(+67.1%) |
| Mar 2007 | - | $1.89 M(+83.7%) |
| Dec 2006 | $1.03 M(+149.1%) | $1.03 M(+40.8%) |
| Sept 2006 | - | $728.80 K(-35.0%) |
| June 2006 | - | $1.12 M(-2.5%) |
| Mar 2006 | - | $1.15 M(+178.9%) |
| Dec 2005 | $412.10 K(-66.0%) | $412.10 K(-43.2%) |
| Sept 2005 | - | $725.50 K(-12.0%) |
| June 2005 | - | $824.40 K(+9.0%) |
| Mar 2005 | - | $756.20 K(-37.6%) |
| Dec 2004 | $1.21 M(-18.0%) | $1.21 M(-10.6%) |
| Sept 2004 | - | $1.36 M(+25.4%) |
| June 2004 | - | $1.08 M(-34.6%) |
| Mar 2004 | - | $1.65 M(+11.9%) |
| Dec 2003 | $1.48 M(-29.1%) | $1.48 M(-30.2%) |
| Sept 2003 | - | $2.12 M(+3.8%) |
| June 2003 | - | $2.04 M(-24.1%) |
| Mar 2003 | - | $2.69 M(+28.9%) |
| Dec 2002 | $2.09 M(-21.1%) | $2.09 M(-9.7%) |
| Sept 2002 | - | $2.31 M(-2.4%) |
| June 2002 | - | $2.37 M(-17.4%) |
| Mar 2002 | - | $2.87 M(+8.4%) |
| Dec 2001 | $2.64 M(-18.9%) | $2.64 M(-11.2%) |
| Sept 2001 | - | $2.98 M(+10.7%) |
| June 2001 | - | $2.69 M(-19.6%) |
| Mar 2001 | - | $3.35 M(+2.6%) |
| Dec 2000 | $3.26 M(+149.5%) | $3.26 M(-1.6%) |
| Sept 2000 | - | $3.31 M(-7.1%) |
| June 2000 | - | $3.57 M(-25.9%) |
| Mar 2000 | - | $4.82 M(+268.6%) |
| Dec 1999 | $1.31 M(-64.6%) | $1.31 M(-40.5%) |
| Sept 1999 | - | $2.20 M(-15.0%) |
| June 1999 | - | $2.59 M(-7.6%) |
| Mar 1999 | - | $2.80 M(-24.0%) |
| Dec 1998 | $3.69 M(+47.6%) | $3.69 M(-3.2%) |
| Sept 1998 | - | $3.81 M(-26.8%) |
| June 1998 | - | $5.20 M(+37.0%) |
| Mar 1998 | - | $3.80 M(+52.0%) |
| Dec 1997 | $2.50 M | $2.50 M(-19.4%) |
| Sept 1997 | - | $3.10 M(-26.2%) |
| June 1997 | - | $4.20 M |
FAQ
- What is Nymox Pharmaceutical annual stockholders equity?
- What is the all time high annual shareholders equity for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual stockholders equity?
The current annual shareholders equity of NYMX is -$482.00 K
What is the all time high annual shareholders equity for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual stockholders equity is $7.00 M
What is Nymox Pharmaceutical quarterly stockholders equity?
The current quarterly shareholders equity of NYMX is -$1.80 M
What is the all time high quarterly shareholders equity for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly stockholders equity is $10.09 M